HPV16 infection of HaCaTs is dependent on β4 integrin, and α6 integrin processing

Virology

Volumn 449, Issue , 2014, Pages 45-52

  Aksoy, Pinar ^a   Abban, Cynthia Y ^a,b   Kiyashka, Elizabeth ^a   Qiang, Weitao ^a,c   Meneses, Patricio I ^a  

^a FORDHAM UNIVERSITY   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

HaCaTs; HPV; Virus entry; 6 Integrin; 4 Integrin

Indexed keywords

ALPHA3 INTEGRIN; ALPHA6 INTEGRIN; ALPHA6BETA4 INTEGRIN; BETA1 INTEGRIN; BETA4 INTEGRIN;

ARTICLE; CELL LINE; CONTROLLED STUDY; ENDOCYTOSIS; GENE SILENCING; HACAT CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16 INFECTION; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

HUMAN PAPILLOMAVIRUS;

HACATS; HPV; VIRUS ENTRY; Α6 INTEGRIN; Β4 INTEGRIN;

CELL LINE, TUMOR; HUMAN PAPILLOMAVIRUS 16; HUMANS; INTEGRIN ALPHA6; INTEGRIN BETA4; PAPILLOMAVIRUS INFECTIONS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA INTERFERENCE;

EID: 84888026807     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.10.034     Document Type: Article

References (29)

1. Abban C.Y., Meneses P.I. Usage of heparan sulfate, integrins, and FAK in HPV16 infection. Virology 2010, 403:1-16.
2. Bienkowska-Haba M., Patel H.D., Sapp M. Target cell cyclophilins facilitate human papillomavirus type 16 infection. PLoS Pathogens 2009, 5:e1000524.
3. Day P.M., Gambhira R., Roden R.B., Lowy D.R., Schiller J.T. Mechanisms of human papillomavirus type 16 neutralization by 12 cross-neutralizing and l1 type-specific antibodies. J. Virol. 2008, 82:4638-4646.
4. Delwel G.O., Hogervorst F., Sonnenberg A. Cleavage of the alpha6A subunit is essential for activation of the alpha6Abeta1 integrin by phorbol 12-myristate 13-acetate. J. Biol. Chem. 1996, 271:7293-7296.
5. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. (Lond.) 2006, 110:525-541.
6. Doorbar J., Quint W., Banks L., Bravo I.G., Stoler M., et al. The biology and life-cycle of human papillomaviruses. Vaccine 2012, 30(5):F55-F70.
7. Dziduszko A., Ozbun M.A. Annexin A2 and S100A10 regulate human papillomavirus type 16 entry and intracellular trafficking in human keratinocytes. J. Virol. 2013, 87:7502-7515.
8. Evander M., Frazer I.H., Payne E., Qi Y.M., Hengst K., et al. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J. Virol. 1997, 71:2449-2456.
9. Giroglou T., Florin L., Schafer F., Streeck R.E., Sapp M. Human papillomavirus infection requires cell surface heparan sulfate. J. Virol. 2001, 75:1565-1570.
10. Goldfinger L.E., Hopkinson S.B., deHart G.W., Collawn S., Couchman J.R., et al. The alpha3 laminin subunit, alpha6beta4 and alpha3beta1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin. J. Cell Sci. 1999, 112(Pt 16):2615-2629.
11. Huang H.S., Lambert P.F. Use of an in vivo animal model for assessing the role of integrin alpha(6)beta(4) and syndecan-1 in early steps in papillomavirus infection. Virology 2012, 433:395-400.
12. Johnson K.M., Kines R.C., Roberts J.N., Lowy D.R., Schiller J.T., et al. Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J. Virol. 2009, 83:2067-2074.
13. Joyce J.G., Tung J.S., Przysiecki C.T., Cook J.C., Lehman E.D., et al. The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J. Biol. Chem. 1999, 274:5810-5822.
14. Kligys K.R., Wu Y., Hopkinson S.B., Kaur S., Platanias L.C., et al. alpha6beta4 integrin, a master regulator of expression of integrins in human keratinocytes. J. Biol. Chem. 2012, 287:17975-17984.
15. Laniosz V., Dabydeen S.A., Havens M.A., Meneses P.I. Human papillomavirus type 16 infection of human keratinocytes requires clathrin and caveolin-1 and is brefeldin a sensitive. J. Virol. 2009, 83:8221-8232.
16. Lehmann M., Rigot V., Seidah N.G., Marvaldi J., Lissitzky J.C. Lack of integrin alpha-chain endoproteolytic cleavage in furin-deficient human colon adenocarcinoma cells LoVo. Biochem. J. 1996, 317(Pt 3):803-809.
17. Lipovsky A., Popa A., Pimienta G., Wyler M., Bhan A., et al. Genome-wide siRNA screen identifies the retromer as a cellular entry factor for human papillomavirus. Proc. Natl. Acad. Sci. USA 2013, 110:7452-7457.
18. Lissitzky J.C., Luis J., Munzer J.S., Benjannet S., Parat F., et al. Endoproteolytic processing of integrin pro-alpha subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7. Biochem. J. 2000, 346(Pt 1):133-138.
19. Margadant C., Raymond K., Kreft M., Sachs N., Janssen H., et al. Integrin alpha3beta1 inhibits directional migration and wound re-epithelialization in the skin. J. Cell Sci. 2009, 122:278-288.
20. Richards R.M., Lowy D.R., Schiller J.T., Day P.M. Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc. Natl. Acad. Sci USA 2006, 103:1522-1527.
21. Roberts J.N., Buck C.B., Thompson C.D., Kines R., Bernardo M., et al. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat. Med. 2007, 13:857-861.
22. Scheffer K.D., Gawlitza A., Spoden G.A., Zhang X.A., Lambert C., et al. Tetraspanin CD151 mediates papillomavirus type 16 endocytosis. J. Virol. 2013, 87:3435-3446.
23. Schiffman M. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing. Cancer 2007, 111:145-153.
24. Seidah N.G., Prat A. The biology and therapeutic targeting of the proprotein convertases. Nat. Rev. Drug. Discov. 2012, 11:367-383.
25. Selinka H.C., Florin L., Patel H.D., Freitag K., Schmidtke M., et al. Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. J. Virol. 2007, 81:10970-10980.
26. Surviladze Z., Dziduszko A., Ozbun M.A. Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections. PLoS Pathogens 2012, 8:e1002519.
27. Takada Y., Ye X., Simon S. The integrins. Genome Biol. 2007, 8:215.
28. Woodham A.W., Da Silva D.M., Skeate J.G., Raff A.B., Ambroso M.R., et al. The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection. PLoS One 2012, 7:e43519.
29. Yoon C.S., Kim K.D., Park S.N., Cheong S.W. alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP. Biochem. Biophys. Res. Commun. 2001, 283:668-673.